📰 Peginterferon Lambda News
Page 2 - Peginterferon Lambda News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peginterferon Lambda. Real-time updates on events, politics, business and more.
May 10, 2022
/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...
May 10, 2022
PALO ALTO, Calif. and OSAKA, Japan, May 10, 2022 /PRNewswire/ -- Eiger Biopharmaceuticals Inc. and AnGes Inc. today announced that the companies entered into an agreement for the regulatory...
May 10, 2022
/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...
May 8, 2022
Eiger BioPharmaceuticals, Inc. (NASDAQ:NASDAQ:EIGR) Q1 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Sarah Mathieson - Senior Vice President-Corporate Affairs...
May 5, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
April 19, 2022
Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments - read this article along with other careers information, tips and advice on BioSpace
March 19, 2022
An experimental treatment greatly reduced the risk of hospitalization and emergency room visits in people who contracted COVID-19, ...
March 18, 2022
Investigational drug Lambda reduced risk of COVID-19-related death in one of the largest studies of its kind to date.
March 16, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
March 16, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...